UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

A phase II Trial of etanercept a recombinant human soluble tumour necrosis factor receptor (p75) fusion protein in patients with metastatic breast cancer.

Madhusudan, S; Braybrooke, JP; Forster, M; Wilner, S; Han, C; Kaur, K; Balkwill, F; ... Harris, AL; + view all (2003) A phase II Trial of etanercept a recombinant human soluble tumour necrosis factor receptor (p75) fusion protein in patients with metastatic breast cancer. In: (Proceedings) AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. (pp. 6192S-6192S). AMER ASSOC CANCER RESEARCH

Full text not available from this repository.
Type: Proceedings paper
Title: A phase II Trial of etanercept a recombinant human soluble tumour necrosis factor receptor (p75) fusion protein in patients with metastatic breast cancer.
Event: AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Location: BOSTON, MASSACHUSETTS
Dates: 17 November 2003 - 21 November 2003
Keywords: Science & Technology, Life Sciences & Biomedicine, Oncology
UCL classification: UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology
URI: http://discovery.ucl.ac.uk/id/eprint/10029213
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item